Low Normal Cerebrospinal Fluid A-beta-42 Levels Predict Clinical Progression in Nondemented Subjects

Betty M. Tijms*, Daniela Bertens, Rosalinde E. Slot, Alida A. Gouw, Charlotte E. Teunissen, Philip Scheltens, Wiesje M. van der Flier, Pieter Jelle Visser

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)749-753
Number of pages5
JournalAnnals of Neurology
Volume81
Issue number5
DOIs
Publication statusPublished - May 2017

Keywords

  • MILD COGNITIVE IMPAIRMENT
  • ALZHEIMERS ASSOCIATION WORKGROUPS
  • BETA-AMYLOID 42
  • DIAGNOSTIC GUIDELINES
  • NATIONAL INSTITUTE
  • DISEASE
  • BIOMARKERS
  • DEMENTIA
  • TAU
  • RECOMMENDATIONS

Cite this

Tijms, B. M., Bertens, D., Slot, R. E., Gouw, A. A., Teunissen, C. E., Scheltens, P., van der Flier, W. M., & Visser, P. J. (2017). Low Normal Cerebrospinal Fluid A-beta-42 Levels Predict Clinical Progression in Nondemented Subjects. Annals of Neurology, 81(5), 749-753. https://doi.org/10.1002/ana.24921